These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36872467)

  • 1. Estimation of the selected treatment mean in two stage drop-the-losers design.
    Masihuddin ; Misra N
    J Biopharm Stat; 2024 Mar; 34(2):164-189. PubMed ID: 36872467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials.
    Bowden J; Glimm E
    Biom J; 2014 Mar; 56(2):332-49. PubMed ID: 24353149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjusting for treatment selection in phase II/III clinical trials with time to event data.
    Khan JN; Kimani PK; Glimm E; Stallard N
    Stat Med; 2023 Jan; 42(2):146-163. PubMed ID: 36419206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Bayesness, minimaxity and admissibility of point estimators of allelic frequencies.
    Martínez CA; Khare K; Elzo MA
    J Theor Biol; 2015 Oct; 383():106-15. PubMed ID: 26271891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection.
    Carreras M; Brannath W
    Stat Med; 2013 May; 32(10):1677-90. PubMed ID: 22744936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints.
    Di Stefano F; Pannaux M; Correges A; Galtier S; Robert V; Saint-Hilary G
    Stat Med; 2022 May; 41(10):1767-1779. PubMed ID: 35098579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of common location parameter of several heterogeneous exponential populations based on generalized order statistics.
    Azhad QJ; Arshad M; Misra AK
    J Appl Stat; 2021; 48(10):1798-1815. PubMed ID: 35706710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimax Estimation of Functionals of Discrete Distributions.
    Jiao J; Venkat K; Han Y; Weissman T
    IEEE Trans Inf Theory; 2015 May; 61(5):2835-2885. PubMed ID: 29375152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the log-normal mean.
    Zhou XH
    Stat Med; 1998 Oct; 17(19):2251-64. PubMed ID: 9802182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point estimation following a two-stage group sequential trial.
    Grayling MJ; Wason JM
    Stat Methods Med Res; 2023 Feb; 32(2):287-304. PubMed ID: 36384365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the inadmissibility of Watterson's estimator.
    Futschik A; Gach F
    Theor Popul Biol; 2008 Mar; 73(2):212-21. PubMed ID: 18215409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient estimation of log-normal means with application to pharmacokinetic data.
    Shen H; Brown LD; Zhi H
    Stat Med; 2006 Sep; 25(17):3023-38. PubMed ID: 16345103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point estimation in adaptive enrichment designs.
    Kunzmann K; Benner L; Kieser M
    Stat Med; 2017 Nov; 36(25):3935-3947. PubMed ID: 28783881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval estimation in multi-stage drop-the-losers designs.
    Lu X; He Y; Wu SS
    Stat Methods Med Res; 2018 Jan; 27(1):221-233. PubMed ID: 26980742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameter estimation following an adaptive treatment selection trial design.
    Luo X; Wu SS; Xiong J
    Biom J; 2010 Dec; 52(6):823-35. PubMed ID: 21154898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What inference for two-stage phase II trials?
    Porcher R; Desseaux K
    BMC Med Res Methodol; 2012 Aug; 12():117. PubMed ID: 22867439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.